// App-Quantinova.ai

: Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

Researchers

Presenter

  • S.Gillessen

Principal Investigators

  • G.Attard

  • J.S.de Bono

  • E.Efstathiou

  • K.Fizazi

  • S.Halabi

  • P.S.Nelson

  • O.Sartor

  • M.R.Smith

  • H.R.Soule

  • H.Akaza

  • T.M.Beer

  • H.Beltran

  • A.M.Chinnaiyan

  • G.Daugaard

  • I.D.Davis

  • M.De Santis

  • C.G.Drake

  • R.A.Eeles

  • S.Fanti

  • M.E.Gleave

  • A.Heidenreich

  • M.Hussain

  • N.D.James

  • F.E.Lecouvet

  • C.J.Logothetis

  • K.Mastris

  • S.Nilsson

  • W.K.Oh

  • D.Olmos

  • A.R.Padhani

  • C.Parker

  • M.A.Rubin

  • J.A.Schalken

  • H.I.Scher

  • A.Sella

  • N.D.Shore

  • E.J.Small

  • C.N.Sternberg

  • H.Suzuki

  • C.J.Sweeney

  • I.F.Tannock

  • B.Tombal

Medical Centers

  • Department of Oncology/Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland

  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK

  • Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston

  • Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA

  • Dept. of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Department of Cancer Medicine, Institut Gustave Roussy, Paris-Sud University, Villejuif, France

  • Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC

  • Dept. of Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Tulane Cancer Centre, Tulane University, New Orleans

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Prostate Cancer Foundation, Santa Monica, CA

  • Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan

  • Oregon Health & Science University, OHSU Knight Cancer Institute, Portland, OR

  • Department of Pharmacology, Weill Cornell Medical College, New York, NY

  • Michigan Centre for Translational Pathology, Department of Pathology

  • Department of Urology, Comprehensive Cancer Centre

  • Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA

  • Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark

  • Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia

  • Cancer Research Centre, University of Warwick, Warwick, UK

  • Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria

  • Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA

  • The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK

  • Unit of Internal Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy

  • Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada

  • Klinik und Poliklinik fuer Urologie, RWTH University Aachen, Aachen, Germany

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

  • Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK

  • Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium

  • Europa Uomo Prostate Patients, Clayhall Ilford, UK

  • Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

  • Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

  • Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  • CNIO-IBIMA Genitorurinary Cancer Clinical Research Unit, Hospitales Universitarios Virgen de la Victoria & Regional de Malaga, Malaga, Spain

  • Centro Intengral Oncologico Clara campal, Madrid, Spain

  • Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London, United Kingdom

  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK

  • Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

  • Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel

  • Department of Urology, Carolina Urologic Research Centre, Myrtle Beach

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

  • Department of Urology, Teikyo University Chiba Medical Center, Chiba, Japan

  • Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Womens Hospital, Harvard Medical School, Boston, MA

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Institut de Recherche Clinique, Universite Catholique de Louvain, Brussels, Belgium

Locations

  • Switzerland

  • United Kingdom

  • United States

  • Greece

  • France

  • Japan

  • Denmark

  • Australia

  • Austria

  • Italy

  • Canada

  • Germany

  • Belgium

  • Sweden

  • Spain

  • Netherlands

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved